Chilton Capital Management
MED icon

Chilton Capital Management’s Medifast MED Stock Holding History

Chilton Capital Management’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-50
Closed -$10K – 448
2021
Q4 		$10K Buy
+50
New +$10.3K ﹤0.01% 499

Other funds holding MED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Pictet Asset Management (Switzerland)
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Chilton Capital Management's MED Position: Q1 2022 in Review

Chilton Capital Management sold out of Medifast (MED) in Q1 2022, closing a stake of 50 shares — an estimated $10K sold.

Chilton Capital Management first reported a position in MED in Q4 2021 and held it in 1 quarter. The position peaked at $10K in Q4 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

  • Chilton Capital Management reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
  • Chilton Capital Management sold 50 Medifast shares in Q1 2022, an estimated $10K.
  • Chilton Capital Management first reported a position in Medifast in Q4 2021 and held it in 1 quarter.
  • Chilton Capital Management's Medifast position peaked at $10K in Q4 2021.
  • 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Chilton Capital Management's 13F filing for Q1 2022, filed 16 May 2022.